[1]
|
Steliarova-Foucher, E., Colombet, M., Ries, L.A.G., Moreno, F., Dolya, A., Bray, F., et al. (2017) International Inci-dence of Childhood Cancer, 2001-10: A Population-Based Registry Study. The Lancet Oncology, 18, 719-731.
https://doi.org/10.1016/S1470-2045(17)30186-9
|
[2]
|
Mezgebu, E., Anwarali, S., Durañona, M. and Challinor, J. (2021) Pediatric Oncology Nursing Research in Low- and Middle-Income Countries: Exemplars from Three Regions. Seminars in Oncology Nursing, 37, Article ID: 151168.
https://doi.org/10.1016/j.soncn.2021.151168
|
[3]
|
Gatta, G., Botta, L., Rossi, S., Aareleid, T., Bielska-Lasota, M., Clavel, J., et al. (2014) Childhood Cancer Survival in Europe 1999-2007: Results of Eurocare-5—A Population-Based Study. The Lancet Oncology, 15, 35-47.
https://doi.org/10.1016/S1470-2045(13)70548-5
|
[4]
|
Betz, C.L. (2018) Promoting Excellence in Pediatric Nursing Practice and Science. Journal of Pediatric Nursing, 38, i-iii. https://doi.org/10.1016/j.pedn.2017.11.016
|
[5]
|
Laserna Jiménez, C., López Poyato, M., Casado Montañés, I., Guix-Comellas, E.M. and Fabrellas, N. (2021) Paediatric Nursing Clinical Competences in Primary Healthcare: A Sys-tematic Review. Journal of Advanced Nursing, 77, 2662-2679. https://doi.org/10.1111/jan.14768
|
[6]
|
Brok, J., Treger, T.D., Gooskens, S.L., van den Heuvel-Eibrink, M.M. and Pritchard-Jones, K. (2016) Biology and Treatment of Renal Tumours in Childhood. European Journal of Cancer, 68, 179-195.
https://doi.org/10.1016/j.ejca.2016.09.005
|
[7]
|
Szychot, E., Apps, J. and Pritchard-Jones, K. (2014) Wilms’ Tumor: Biology, Diagnosis and Treatment. Translational Pediatrics, 3, 12-24.
|
[8]
|
Oostveen, R.M. and Pritchard-Jones, K. (2019) Pharmacotherapeutic Management of Wilms Tumor: An Update. Paediatric Drugs, 21, 1-13. https://doi.org/10.1007/s40272-018-0323-z
|
[9]
|
Grundy, P.E., Breslow, N.E., Li, S., Perlman, E., Beckwith, J.B., Ritchey, M.L., et al. (2005) Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report from the National Wilms Tumor Study Group. Journal of Clinical Oncol-ogy, 23, 7312-7321.
https://doi.org/10.1200/JCO.2005.01.2799
|
[10]
|
Pritchard-Jones, K., Bergeron, C., De Camargo, B., van den Heuvel-Eibrink, M.M., Acha, T., Godzinski, J., et al. (2015) Omission of Doxorubicin from the Treatment of Stage II-III, Intermediate-Risk Wilms’ Tumour (SIOP WT 2001): An Open-Label, Non-Inferiority,Randomised Controlled Trial. Lancet, 386, 1156-1164.
https://doi.org/10.1016/S0140-6736(14)62395-3
|
[11]
|
Croteau, N., Nuchtern, J. and Laquaglia, M.P. (2021) Man-agement of Neuroblastoma in Pediatric Patients. Surgical oncology clinics of North America, 30, 291-304. https://doi.org/10.1016/j.soc.2020.11.010
|
[12]
|
Ackermann, S., Cartolano, M., Hero, B., Welte, A., Kahlert, Y., Roderwieser, A., et al. (2018) A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Science, 362, 1165-1170. https://doi.org/10.1126/science.aat6768
|
[13]
|
Whittle, S.B., Smith, V., Doherty, E., Zhao, S., McCarty, S. and Zage, P.E. (2017) Overview and Recent Advances in the Treatment of Neuroblastoma. Expert Review of Anti-cancer Therapy, 17, 369-386.
https://doi.org/10.1080/14737140.2017.1285230
|
[14]
|
Pinto, N.R., Applebaum, M.A., Volchenboum, S.L., Mat-thay, K.K., London, W.B., Ambros, P.F., et al. (2015) Advances in Risk Classification and Treatment Strategies for Neuroblastoma. Journal of Clinical Oncology, 33, 3008-3017.
https://doi.org/10.1200/JCO.2014.59.4648
|
[15]
|
Abramson, D.H. (2014) Retinoblastoma: Saving Life with Vision. Annual Review of Medicine, 65, 171-184.
https://doi.org/10.1146/annurev-med-061312-123455
|
[16]
|
Kato, M.A., Green, N., O’connell, K., Till, S.D., Kramer, D.J., Al-Khelaifi, M., et al. (2015) A Retrospective Analysis of Severe Intraoperative Respiratory Compliance Changes during Ophthalmic Arterial Chemosurgery for Retinoblastoma. Paediatricanaesthesia, 25, 595-602. https://doi.org/10.1111/pan.12603
|
[17]
|
Aerts, I., Sastre-Garau, X., Savignoni, A., Lumbroso-Le Rouic, L., The-baud-Leculée, E., Frappaz, D., et al. (2013) Results of a Multicenter Prospective Study on the Postoperative Treatment of Unilateral Retinoblastoma after Primary Enucleation. Journal of Clinical Oncology, 31, 1458-1463. https://doi.org/10.1200/JCO.2012.42.3962
|
[18]
|
Leclerc, R. and Olin, J. (2020) An Overview of Retinoblastoma and Enucleation in Pediatric Patients. AORN Journal, 111, 69-79. https://doi.org/10.1002/aorn.12896
|
[19]
|
Whitlock, R.S., Portuondo, J.I., Commander, S.J., Ha, T.A., Zhu, H., Goss, J.A., et al. (2022) Integration of a Dedicated Manage-ment Protocol in the Care of Pediatric Liver Cancer: From Specialized Providers to Complication Reduction. Journal of Pediatric Surgery, 57, 1544-1553. https://doi.org/10.1016/j.jpedsurg.2021.07.012
|
[20]
|
Ranganathan, S., Lopez-Terrada, D. and Alaggio, R. (2020) Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatric and Developmental Pathology, 23, 79-95. https://doi.org/10.1177/1093526619875228
|
[21]
|
Agarwala, S. (2012) Primary Malignant Liver Tumors in Children. Indian Journal of Pediatrics, 79, 793-800.
https://doi.org/10.1007/s12098-012-0704-1
|
[22]
|
Becker, K., Furch, C., Schmid, I., von Schweinitz, D. and Häberle, B. (2015) Impact of Postoperative Complications on Overall Survival of Patients with Hepatoblastoma. Pediatric Blood & Cancer, 62, 24-28.
https://doi.org/10.1002/pbc.25240
|